Genomic biomarkers in relation to PD-1 checkpoint blockade response.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.5_suppl.25
Abstract: 25Background: Somatic tumor mutational burden (TMB) and a T-cell inflamed gene expression profile (GEP) predict response to anti-PD-1/PD-L1 immunotherapies in multiple tumor types. We assessed the potential for GEP and TMB to jointly predict clinical… read more here.
Keywords: gep low; response; genomic biomarkers; tmb ... See more keywords